No menu items!

Butantan may delay vaccine deliveries due to an API shortage

RIO DE JANEIRO, BRAZIL - The Butantan Institute may delay delivery of the CoronaVac vaccine to the Ministry of Health, due to a shortage of active pharmaceutical ingredient (API) imported from China. The Institute's president Dimas Covas blamed president Jair Bolsonaro's government stance toward the Asian country for this delay.

At a press conference to mark the delivery of a shipment of 1 million doses of the vaccine to the Ministry's National Immunization Program (PNI), Covas said the delay in the delivery of API is not due to production issues of Sinovac, which supplies Brazil with the raw . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?

Check out our other content